cause the repeal of the medical cannabis chapter upon the federal re-scheduling of cannabis.

SB 181 would end South Dakota's medical cannabis program if the federal government reclassifies cannabis as a Schedule III drug under federal law. It specifically repeals the state's medical cannabis chapter (Chapter 34-20G) upon confirmation by the attorney general that the U.S. Food and Drug Administration has made this federal change. The law requires the Department of Health to notify all current medical cannabis cardholders and licensed businesses about the repeal and its effective date. This change only affects South Dakota's medical cannabis program and would not impact recreational cannabis laws or other state regulations.